In Vitro Technologies enables researchers to accelerate discovery when investigating both the impacts of neurotransmitters and to analyse neurotransmitter and neuroreceptor expression with a unique portfolio of reagents and equipment specialised for neurotransmission research.
Human induced pluripotent stem cell (iPSC)–derived neurospheres provide an advanced in vitro system for modeling the human brain.
In Vitro Technologies is proud to present the Infors Minifors 2. Discover the latest generation Minifors 2, the compact and easy-to-use bioreactor.
Free Laboratory Equipment Health Check*No matter what kind of laboratory equipment you use, it must we be well maintained to enhance the efficiency of laboratory procedures and scientific research.
Happy #InternationalWomensDay2022!
Start your new lab with quality products for quality research, with the New Lab Program from In Vitro Technologies! Our unique portfolio features an exclusive array of quality equipment and...
In this poster, you'll find essential information on how to use your industrial evaporator most efficiently. Learn how to:
Solidify your grasp of fundamental basics and gain additional tips and tricks on:> Purification via reversed-phase chromatography> Concentration via rotary evaporation or freeze drying> Formulation with spray drying or freeze...
BUCHI Webinar | Join a theory and lab-based session on common techniques used in discovery and development of proteins and peptides.
Dr. Jesús F Bermejo-Martín is the Principal Investigator, Group For Biomedical Research in Respiratory Infection and Sepsis (BioSepsis) at the Institute of Biomedical Research of Salamanca (IBSAL) / Hospital Universitario...
To support your cell culture techniques, In Vitro Technologies present a range of top 50 cell culture FAQs to ensure that you have all the information you need to be...
Join us for the latest Radley's webinar: "Benefits of Overhead Stirring on a Small-Scale"
Wednesday 14th & Thursday 15th of July!
In Vitro Technologies is committed to providing essential products to the scientific and medical community, especially during the current, quickly changing circumstances caused by the corona virus (COVID-19) outbreak.
In October of 2019, the Nobel Assembly announced the award of the 2019 Nobel Prize jointly to William G. Kaelin, Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza in Physiology or Medicine. This award is to acknowledge their scientific discoveries of how cells sense and adapt to oxygen availability.
In Vitro Technologies are proud to announce two upcoming seminars detailing ACD Bio RNAscope® technology, a unique technology enabling RNA target expression analysis within intact cells and tissues with high sensitivity and specificity.
ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence. The portal, which launched with an initial 250 genome sequences of widely used bacterial strains, delivers on ATCC’s Enhanced Authentication Initiative, a component of the first of five core pledges under the Incredible 2020 Initiative aimed at increasing reproducibility in biological research.
ATCC today announced the launch of a new authentication service that will allow researchers to easily confirm the identity of mouse cell lines. Developed in partnership with the National Institutes for Standards and Technology (NIST), the service demonstrates ATCC’s continued leadership in developing global biological standards.
The Bioprocessing Network Australia (BPN) has selected Probiotics Australia as the site for the next QLD satellite event now that Probiotics Australia has been launched and started production.
Probiotics Australia is a purpose built, cutting-edge bio-manufacturing facility, located in Ormeau, Queensland, it was officially opened in May 2019. The TGA cGMP licensed facility houses research, development and production laboratories in addition to sizable warehousing and offices. The site is also certified by Australian Certified Organic, HACCP approved, and FDA registered.
ATCC Pledges to Advance Authentication
Are you willing to stake the integrity of your research on potentially unreliable starting materials? Your incredible advancements are too important to risk.
In ATCC's latest short documentary film, “Next-Generation Biological Models: Revolutionizing Cancer Research,” they focus on the Human Cancer Models Initiative (HCMI), a groundbreaking international research collaboration to transform cancer research and therapeutic development.
Recently, Tocris announced the release of some new Chemogenetic tools for Neuroscience research - PSEMs, pharmacologically selective effector molecules.
We are very pleased to announce that Polyplus-transfection® SA, has trusted In Vitro Technologies as their new exclusive distributor in Australia and New Zealand.
Located close to the University of Strasbourg in France, Polyplus-transfection® SA is a biotechnology company that develops and sells innovative, high efficiency transfection reagents for the delivery of nucleic acids in research, bioproduction and therapeutics.
We are very pleased to announce that Terumo BCT has appointed In Vitro Technologies as their new distributor in Australia and New Zealand effective 1 June 2018, supporting the Cell Therapy Technologies range of products.
ATCC's toxicological tools can also be used to identify responses to environmental insults or to screen pharmaceutical compounds. These cells are applicable for bench work and large-scale screening and are fully characterized and functionally tested.
ATCC has updated the White Paper Synthetic Nucleic Acids for the Development and Evaluation of In Vitro Diagnostic Devices Designed to Detect Dengue, Chikungunya, and Zika White Paper.
To support Australian and New Zealand research in the fight against cancer, In Vitro Technologies offered 5 Travel Grants to Australian and New Zealand researchers to attend the Eradicate Cancer Conference in Melbourne in March 2018. And the winners are...
Great publication about improving the efficacy of adoptive T-Cell therapy in solid tumours by using 3rd generation CAR-T cells.
Scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
In Vitro Technologies would like to congratulate Dr. Andreas Behren and the Cancer Immunobiology team at the Olivia Newton-John Cancer Research (ONJCRI) Institute in Melbourne for winning the Advanced Cell Diagnostics $40,000 USD research grant.
In Vitro Technologies are proud to work closely with the new NSW Health Statewide Biobank, the largest biobank in the southern hemisphere.
In the latest vote of confidence that cellular immunotherapy is going to live up to its potential for transforming the way cancer is treated, this week Gilead Sciences purchased Kite Pharma, a leader in the development of chimeric antigen receptor (CAR) T cells, for $11.9 billion dollars.
Proteome Profiler™ Antibody Arrays allow for the measurement of up to 119 proteins in a single sample.
MANASSAS, VA (August 8, 2017) — ATCC, a global leader in biological materials development, management, and standards, in partnership with the Institute for Life Science Entrepreneurship (ILSE) and the ATCC...
Join us at the Protein Expression Workshop meeting for a hands-on demonstration of the new Minifors 2 from Infors-HT and the new eve bioprocess control software.
Enter below to win a FREE Allentown Service and NATA Certification.
Findings from the new study—published recently in the Journal of Medicinal Chemistry in an article entitled “Development of a Potent Wound Healing Agent Based on the Liver Fluke Granulin Structural...
During the workshop, we learnt how the xCelligence from ACEA Bioscience employs non-invasive impedance microelectrodes in automated high-throughput plate formats to maximize the physiological relevance of data extracted from in...
For 20 years scientists have relied on R&D Systems® antibodies for quality and reproducibility. Watch a recent webinar that discusses design and testing tips to help validate your antibodies and ensure the reproducibility of your data.
In Vitro Technologies are proud to invite Dr Yuling Luo, President of Advanced Cell Diagnostics to present a seminar series on Next Generation RNA In Situ Hybridization Technologies For Research and Diagnostics in Melbourne, Sydney & Brisbane from the 22nd – 25th May 2017.
The workshop will be held at: xCELLigence Real Time Cell Analysis Workshop Lab,Theatre B, Victorian Comprehensive Cancer Centre. Monday 15th May, 3:00PM - 4:30PM.
eve® is the platform for big data in bioprocesses. It uses cutting-edge NoSQL technology instead of traditional SQL.
Recent advances in the field of stem cell biology have enabled the in vitro generation of complex 3D structures resembling whole organs, referred to as organoids.
Recombinant proteins and small molecules are routinely used to manipulate signalling pathways in cell culture. Modulating the pathways is important in stem cell research to either maintain a pool of...
Chimeric antigen receptors (CARs) redirect T cell cytotoxicity against cancer cells, providing a promising approach to cancer immunotherapy.
HyClone use a metabolic pathway design approach to make the best bioproduction media. Whether you are growing insect cells, CHO or HEKs; HyClone media will provide optimal cell growth conditions.
The new Minifors 2 benchtop bioreactor from Infors-HT is simple and easy to operate and is a great a starting point for people new to fermentation.
Unlike the innate immune system, the adaptive immune system specifically targets a pathogen with a tailored response.
If you are planning to attend The International Society for Stem Cell Research (ISSCR) Annual Meeting in Boston, USA, in June, let Bio-Techne help you out with one of ten...
The innate immune system, also known as the non-specific immune system, is an important subsystem of the overall immune system that comprises the cells and mechanisms that defend the host...
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand.
We are very pleased to announce that Advanced Cell Diagnostics (ACD) Inc. has appointed In Vitro Technologies as their new exclusive distributor in Australia and New Zealand.
One of the major concerns among the biomedical research community is research reproducibility. It is considered that 50% of published results are irreproducible which leads to a $28 billion loss...
Emerging Instrumentation and Application Trends
Wednesday, 15 February 2017 at 11 AM EST / 8 AM PST / 4 PM GMT
Infectious diseases are caused by biological agents, and produce clinically evident illness in humans. They can be transmitted through a variety of routes, including bodily fluids, animal or insect vectors,...
In Vitro Technologies expands your Immune Checkpoint Blockade research capabilities
Whether you are undertaking basic research or investigating therapeutic intervention in Cancer Immunotherapy, In Vitro Technologies has you covered!
In Vitro Technologies simplifies your work flow in Adoptive T Cell therapy research!
The quarterly ACEA Research Travel Award is open to NovoCyte, xCELLigence, iCELLigence, and RT-CES users who plan to present research using ACEA Biosciences’ technology at scientific conferences. This award will cover travel, registration, meals and housing costs up to $3,000.
Tocris Biosciences enables researchers to study the impacts of neurotransmitters with a wide range of chemical inhibitors and antagonists. The use of small molecule inhibitors and antagonists to facilitate neurotransmission research has helped delineate the pathways involved in many neurodegenerative diseases, as well as providing a solid foundation for the development of future targeted therapeutics. Tocris provides an innovative range of high performance life science reagents for use in neurodegeneration research, equipping researchers with selective pharmacological tools for studying these disease pathways.
The three Rs of Replacement, Reduction and Refinement were established nearly 60 years ago to provide an ethical framework for humane animal research.
High Performance Cell Culture Starts with Highly Authenticated Cells in a Contamination Controlled Environment.
The In-Vitro Cell ES CO2 incubator provides a reliable controlled environment for optimum cell culture growth, and is packed full of features to control contamination.
Improve your performance >
ACEA’s line of real-time cell analyzers has been awarded top honors from Corporate Vision Magazine - for their ability to quantitatively monitor, in a label-free manner, cell number, morphology, and adhesion strength for a broad array of applications.
In Vitro Technologies enables researchers to accelerate discovery when investigating both the impacts of neurotransmitters and to analyse neurotransmitter and neuroreceptor expression with a unique portfolio of reagents and equipment specialised for neurotransmission research.
The In-VitroCell ES CO2 Incubator provides a reliable controlled environment for optimum cell culture growth, and is packed full of features to control contamination.
Launched in July 2016 an international consortium of researchers is looking to revolutionise in vitro Cancer models and drug development. Titled the Human Cancer Model Initiative (HCMI) and spearheaded by the National Cancer Institute (NCI), Cancer Research UK, Welcome Trust Sanger Institute and the Hubrecht Organoid Technology the ambitious collaboration looks to develop 1,000 next-generation cell-line models.
In a Biological Safety Cabinet air flow and motor design are critical for personnel, product, and environmental protection. NuAire’s new LabGard ES offers the very best in consistent performance.
Autophagy is the process by which cells cannibalize their own damaged parts engulfing them in specialised compartments known as autophagosomes before sending them to the trash disposal units of the cell the caustic lysosomes.
A partnership between Allentown, Inc. and Charles River Laboratories - two of Laboratory Animal Science's most trusted and respected companies - has led to the next generation of rodent colony health monitoring, making traditional sentinel animal monitoring programs all but obsolete.
Reduce the risk of cross contamination and increase sample security with Taylor-Wharton Vapour Phase cryopreservation tanks from Worthington Industries.
Allentown recently responded to industry demand for a larger, yet more manageable rat housing with the introduction of NexGen Rat. With 1,800cm2 of floor space and up to 28cm high, the new NexGen Rat 1800 gives rats enough room to stretch out.
For more than 50 years ATCC has been providing neurobiologists with the well-characterized and highly authenticated cells and microorganisms they need to study the nervous system and its associated pathologies.
Mitochondria play central roles in meeting the demands of neuronal synapses for energy (ATP). Mitochondrial dysfunction results in impaired neuroplasticity, neuronal degeneration and cell death, and is now recognized as...
In Vitro Technologies enables researchers to accelerate discovery when investigating both the impacts of neurotransmitters and to analyse neurotransmitter and neuroreceptor expression with a unique portfolio of reagents and equipment specialised for neurotransmission research.
We're extremely excited and proud to announce a new partnership; as of the 1st of July 2015 In Vitro Technologies will be distributors for Novus Biologicals in Australia and New Zealand.
R&D Systems offers a wide range of primary antibodies to cytokines, adhesion molecules, proteases, neurotrophic factors, stem cell factors, signal transduction molecules and developmental proteins.
